My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study.

    Schmid-Kubista KE, Krebs I, Gruenberger B, Zeiler F, Schueller J, Binder S.

    Br J Ophthalmol. 2009 Jul;93(7):914-9. Epub 2009 Apr 29.PMID: 19406737 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

    Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    4.

    Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

    Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

    5.

    A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.

    Algvere PV, Steén B, Seregard S, Kvanta A.

    Acta Ophthalmol. 2008 Aug;86(5):482-9. Epub 2007 Dec 14.PMID: 18162062 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.

    Ophthalmology. 2006 Mar;113(3):363-372.e5. Epub 2006 Feb 3.PMID: 16458968 [PubMed - indexed for MEDLINE]Related articles

    7.

    Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration.

    Yoganathan P, Deramo VA, Lai JC, Tibrewala RK, Fastenberg DM.

    Retina. 2006 Nov-Dec;26(9):994-8.PMID: 17151485 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

    Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

    9.

    Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.

    Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS.

    Ophthalmology. 2005 Jun;112(6):1035-47.PMID: 15936441 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.

    Lazic R, Gabric N.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):68-73. Epub 2006 Nov 18.PMID: 17111146 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.

    Melamud A, Stinnett S, Fekrat S.

    Am J Ophthalmol. 2008 Jul;146(1):91-5. Epub 2008 May 2.PMID: 18455144 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

    Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study.

    Chen CY, Wong TY, Heriot WJ.

    Am J Ophthalmol. 2007 Mar;143(3):510-2. Epub 2006 Nov 13.PMID: 17317398 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments.

    Aggio FB, Farah ME, Silva WC, Melo GB.

    Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):215-20.PMID: 17139490 [PubMed - indexed for MEDLINE]Related articles

    16.

    Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

    Retina. 2006 May-Jun;26(5):495-511.PMID: 16770255 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.

    Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U.

    Am J Ophthalmol. 2007 Dec;144(6):886-892. Epub 2007 Oct 4.PMID: 17916314 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.

    Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN.

    Am J Ophthalmol. 2006 Jul;142(1):1-9.PMID: 16815245 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.

    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.

    Retina. 2007 Sep;27(7):891-6.PMID: 17891013 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of choroidal neovascularization using intravitreal bevacizumab.

    Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

    Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity